Breast cancer vaccine trial recruiting new patients

November 3, 2022

Breast cancer vaccine trial recruiting new patients

A vaccine designed to battle breast cancer is moving to a randomized, Phase II clinical trial after an initial study showed it was safe and effective at targeting HER-2 positive cancers.

Anita Triolo participated in the Phase I study of the vaccine. She was diagnosed with breast cancer at the age of 42 in 2005.

"It's given me I think it's going on 17 years now [in remission]. So, it's given me a lot of extra time with my family," said Triolo. 

"I have very high hopes that it is close to the final step of this vaccine potentially becoming a treatment for patients with breast cancer," said lead author Dr. Mary "Nora" L. Disis, who's a professor of medicine at the University of Washington School of Medicine.

Learn more about the study in our news release. For more details about the research, visit the Cancer Vaccine Institute website.  The phase II trial is recruiting patients; contact the patient coordinator: or 206-543-3829.

Download broadcast-ready soundbites and lab video showcasing the breast cancer vaccine.

UW Medicine

Terms of appropriate usage of file downloads

  • News reporters and news organizations may freely republish and distribute videos, still images and audio files produced by UW Medicine and the University of Washington School of Medicine.
  • Works must be attributed/credited appropriately (for example, “UW Medicine” – as denoted in the file) and must not be used for commercial purposes.
  • These visual and audio files may not be used to exploit or misrepresent UW Medicine or the University of Washington.
  • UW Medicine often licenses still images from Thinkstock but cannot grant republishing rights. You may not republish single image files credited to Thinkstock.
  • Logos of UW Medicine and University of Washington Health Sciences schools may not be republished without explicit permission. Contact us by phone or email: 206.543.3620 or